Skip to content

A study on optimizing medication education based on cross period selection to promote medication compliance in cardiovascular disease patients

A study on optimizing medication education based on cross period selection to promote medication compliance in cardiovascular disease patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118184
Enrollment
Unknown
Registered
2026-02-03
Start date
2024-05-29
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension, coronary atherosclerotic heart disease, diabetes, arrhythmia, heart failure and other diseases

Interventions

Control group:Medication instructions by other medical staff
Medication education pharmacist Group:Medication education
Observation group:N/A

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Heart failure stage A (heart failure risk stage); 2.Stage B (pre-heart failure); 3.Stage C (symptomatic heart failure) patients; 4.Age > 18 years old;

Exclusion criteria

Exclusion criteria: 1. Heart failure Acute stage of heart failure; 2. Patients with combined disease without drug treatment; 3. The hearing-impaired or deaf; 4. inarticulate speech; 5. Mental disorders (mood disorders, depression, anxiety, and personality disorders); 6. Those who quit by themselves; 7. Termination of participants due to changes in disease; 8. Low compatibility or incomplete collection of relevant data.

Design outcomes

Primary

MeasureTime frame
Understanding of Medication Knowledge;

Countries

China

Contacts

Public ContactLiu Nannan

China-Japan Friendship Hospital

lnn_mail@126.com+86 10 8420 5676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026